Guided Therapeutics (GTHP) Treasury Shares (2010 - 2026)

Guided Therapeutics has disclosed Treasury Shares across 17 years of filings, most recently posting $132000.0 for Q2 2026.

• In Q2 2026, Treasury Shares changed 0.0% year-over-year to $132000.0; the TTM figure through Jun 2026 stood at $132000.0 (changed 0.0% YoY), while the FY2025 annual figure was $132000.0, changed 0.0% from the prior year.
• Treasury Shares came in at $132000.0 for Q2 2026 at Guided Therapeutics, roughly flat from $132000.0 in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $678000.0 in Q2 2021 to a low of $678000.0 in Q2 2021.
• Average Treasury Shares over 4 years is $678000.0, with a median of $678000.0 recorded in 2021.
• The largest YoY upside for Treasury Shares was 0.0% in 2022 against a maximum downside of 0.0% in 2022.
• Over 5 years, Treasury Shares stood at $132000.0 in 2022, then changed by 0.0% to $132000.0 in 2023, then changed by 0.0% to $132000.0 in 2024, then changed by 0.0% to $132000.0 in 2025, then changed by 0.0% to $132000.0 in 2026.
• Per Business Quant data, the three most recent Treasury Shares figures were $132000.0 in Q2 2026, $132000.0 in Q1 2026, and $132000.0 in Q4 2025.